lamivudine has been researched along with Cancer of Spleen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deutsch, M; Hatziyanni, E; Manolakopoulos, S; Papadopoulos, N; Vassilopoulos, D | 1 |
| Arcaini, L; Bruno, R; Lucioni, M; Merli, M; Paulli, M; Rattotti, S; Riboni, R; Vercelli, A | 1 |
2 other study(ies) available for lamivudine and Cancer of Spleen
| Article | Year |
|---|---|
Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load.
Topics: Drug Resistance, Viral; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Lymphoma; Male; Middle Aged; Splenic Neoplasms; Viral Load; Virus Activation | 2011 |
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
Topics: Antiviral Agents; Asymptomatic Diseases; Bone Marrow; Carrier State; Cell Transformation, Viral; Disease Progression; Female; Genes, bcl-2; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Follicular; Middle Aged; Neoplasm, Residual; Remission Induction; Splenic Neoplasms | 2011 |